How to deal with the side effects of ruxolitinib tablets/Jiekewei
Ruxolitinib tablets/Ruxolitinib (Ruxolitinib), as a targeted therapy, can significantly improve the quality of life of patients when treating myelofibrosis, graft-versus-host disease and other diseases. However, like most medications, ruxolitinib may cause some side effects. Understanding these side effects and taking appropriate treatments can effectively improve patient outcomes and reduce discomfort.
One of the most common side effects of ruxolitinib is hematological reactions, including anemia and thrombocytopenia. Anemia may cause patients to feel extremely tired and short of breath, while low platelets increase the risk of bleeding. For this situation, doctors usually recommend that patients undergo regular blood tests to monitor hematological indicators. Once a drop in hemoglobin or platelet levels is detected, the doctor may adjust the dose or suspend the medication until blood levels return to normal. For patients with severe anemia, blood transfusions may also be needed.
In addition to hematologic problems, ruxolitinib may cause gastrointestinal discomfort, such as nausea, vomiting, or loss of appetite. These symptoms usually occur early in drug treatment and can be relieved by taking the drug after a meal or using anti-nausea medications. If symptoms persist or worsen, patients should promptly report to their doctor, who may need to adjust their treatment plan.
Ruxolitinib, as an immunosuppressant, may also lead to an increased risk of infection. Patients should take precautions during treatment, such as avoiding contact with sources of infection and maintaining good hygiene. If symptoms of infection occur, your doctor may provide anti-infective treatment and adjust the dose of ruxolitinib based on the condition.
In addition, ruxolitinib may sometimes cause abnormal liver function, and patients should undergo regular liver function tests during treatment. If elevated liver enzymes are found, the doctor may adjust the dose of the drug according to the situation, or suspend use until liver function returns to normal.
Reference materials:https://www.jakavi.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)